Audit of nasal bridle use in Beaumont Hospital

2020 ◽  
Vol 40 ◽  
pp. 678-679
Author(s):  
E.M. Kennedy
Keyword(s):  
Beaumont Hospital

Stereotactic Radiosurgery: The Experience of the Neurotology and Skull Base Unit at Beaumont Hospital

2012 ◽  
Vol 73 (S 02) ◽  
Author(s):  
M. Khan ◽  
M. Sadadcharam ◽  
R. Wormald ◽  
M. Javadpour ◽  
D. Rawluk ◽  
...  
Keyword(s):  
Skull Base ◽  
Stereotactic Radiosurgery ◽  
Beaumont Hospital ◽  
Base Unit

scholarly journals 458. Molecular SARS-CoV-2 Testing During the COVID-19 Outbreak: Experiences of a Hospital in Southeast Michigan, USA

2020 ◽  
Vol 7 (Supplement_1) ◽  
pp. S296-S297
Author(s):  
Trini A Mathew ◽  
Jonathan Hopkins ◽  
Diane Kamerer ◽  
Shagufta N Ali ◽  
Daniel Ortiz ◽  
...  
Keyword(s):  
Clinical Features ◽  
Diagnostic Testing ◽  
Beaumont Hospital ◽  
High Capacity ◽  
Turnaround Time ◽  
Molecular Diagnostic ◽  
The Novel ◽  
Repeat Testing ◽  
Asymptomatic Patients ◽  
Novel Coronavirus

Abstract Background The novel Coronavirus SARS CoV-2 (COVID-19) outbreak was complicated by the lack of diagnostic testing kits. In early March 2020, leadership at Beaumont Hospital, Royal Oak Michigan (Beaumont) identified the need to develop high capacity testing modalities with appropriate sensitivity and specificity and rapid turnaround time. We describe the molecular diagnostic testing experience since initial rollout on March 16, 2020 at Beaumont, and results of repeat testing during the peak of the COVID-19 pandemic in MI. Methods Beaumont is an 1100 bed hospital in Southeast MI. In March, testing was initially performed with the EUA Luminex NxTAG CoV Extended Panel until March 28, 2020 when testing was converted to the EUA Cepheid Xpert Xpress SARS-CoV-2 for quicker turnaround times. Each assay was validated with a combination of patient samples and contrived specimens. Results During the initial week of testing there was > 20 % specimen positivity. As the prevalence grew the positivity rate reached 68% by the end of March (Figure 1). Many state and hospital initiatives were implemented during the outbreak, including social distancing and screening of asymptomatic patients to increase case-finding and prevent transmission. We also adopted a process for clinical review of symptomatic patients who initially tested negative for SARS-CoV-2 by a group of infectious disease physicians (Figure 2). This process was expanded to include other trained clinicians who were redeployed from other departments in the hospital. Repeat testing was performed to allow consideration of discontinuation of isolation precautions. During the surge of community cases from March 16 to April 30, 2020, we identified patients with negative PCR tests who subsequently had repeat testing based on clinical evaluation, with 7.1% (39/551) returning positive for SARS- CoV2. Of the patients who expired due to COVID-19 during this period, 4.3% (9/206) initially tested negative before ultimately testing positive. Figure 1 BH RO testing Epicurve Figure 2: Screening tool for repeat COVID19 testing and precautions Conclusion Many state and hospital initiatives helped us flatten the curve for COVID-19. Our hospital testing experience indicate that repeat testing may be warranted for those patients with clinical features suggestive of COVID-19. We will further analyze these cases and clinical features that prompted repeat testing. Disclosures All Authors: No reported disclosures

scholarly journals Changing Trends in the Management of Esthesioneuroblastoma: Irish and International Perspectives

2017 ◽  
Vol 79 (03) ◽  
pp. 262-268 ◽  
Author(s):  
Thavakumar Subramaniam ◽  
Mary Leader ◽  
Rory McConn-Walsh ◽  
James O'Neill ◽  
Peter Lacy ◽  
...  
Keyword(s):  
Nasal Congestion ◽  
Beaumont Hospital ◽  
Open Approach ◽  
Disease Specific Survival ◽  
Management Options ◽  
Postoperative Radiation Therapy ◽  
Tertiary Referral Center ◽  
Changing Trends ◽  
International Perspectives ◽  
Disease Specific

Objectives Evaluation of the changing trends in esthesioneuroblastoma in an Irish context and review of management options nationally to clarify the best current therapeutic approach by comparing with international research on this uncommon malignancy. Design Retrospective review. Setting Tertiary referral center. Participants All patients presenting with esthesioneuroblastoma in Beaumont hospital or on the National Cancer Registry of Ireland between 1994 and 2013. Main Outcome Measures Recurrence-free and overall survival. Results During the study period, 32 cases of esthesioneuroblastoma were diagnosed (0.4 per million per year). Average age at diagnosis was 57 years; however, two cases were under 20. The majority (62.5%) were male. Patients predominantly presented with epistaxis or nasal congestion (73%), while two cases were identified incidentally on radiological investigations. Twenty-seven cases underwent primary surgical management (two post neo-adjuvant treatment) with seventeen requiring bifrontal craniotomy. Twenty-four of these received postoperative radiation therapy. Overall, 5-year survival was 65%. Kadish A/B patients exhibited 100% 5-year disease-specific survival versus 54% in Kadish C/D (p = 0.011). Hyams grade I/II patients exhibited 75% 5-year disease-specific survival versus 63% in Hyams grade III/IV (p = 0.005). Patients treated endoscopically exhibited 100% 5-year disease-specific survival versus 51% in those treated via an open approach (p = 0.102). Conclusions Many controversies exist in the diagnosis and management of this condition. Despite this, results from Irish data are mostly concordant with the international literature. The rising incidence of this disease may represent improved pathological recognition. An increasing number of esthesioneuroblastoma cases are being successfully treated via endoscopic surgery.

Irish Association For Rheumatology And Rehabilitation Annual General Meeting, Friday, Nov. 4Th At Beaumont Hospital

1989 ◽  
Vol 158 (5) ◽  
pp. 132-136
Author(s):  
O. FitzGerald ◽  
Muriel Soden ◽  
R. Robinson ◽  
B. Bresnihan ◽  
G. Yanni ◽  
...  
Keyword(s):  
Beaumont Hospital ◽  
General Meeting ◽  
Annual General ◽  
Annual General Meeting

scholarly journals AB177. SOH21AS191. Transfer of urology patients to Beaumont Hospital: a quality assurance study & proforma proposal

2021 ◽  
Vol 5 ◽  
pp. AB177-AB177
Author(s):  
Johnathon Harris ◽  
Diarmuid Sugrue ◽  
Sarah Norton ◽  
James Christopher Forde
Keyword(s):  
Quality Assurance ◽  
Beaumont Hospital

Proceedings of the Irish Neurological Association 24th Annual Scientific Meeting, Beaumont Hospital, May 1988

1989 ◽  
Vol 158 (6) ◽  
pp. 158-164
Author(s):  
J. A. O’Dwyer ◽  
J. A. Toland ◽  
M. Geraghty ◽  
O. Hardiman ◽  
M. Keogan ◽  
...  
Keyword(s):  
Beaumont Hospital ◽  
Scientific Meeting ◽  
Annual Scientific ◽  
Annual Scientific Meeting

Diagnostic Significance of Screening for BCR-ABL1 by PCR in Patients with Neutrophilia. The William Beaumont Hospital experience

2015 ◽  
Vol 15 ◽  
pp. S33
Author(s):  
Foluso Ogunleye ◽  
James Huang ◽  
Ibrahim Mohammed ◽  
Emily Allen ◽  
Neil Brennan ◽  
...  
Keyword(s):  
Beaumont Hospital ◽  
Diagnostic Significance ◽  
Hospital Experience

scholarly journals 1653. Strong Partnership and Effective Communication Between a Tertiary Hospital and a County Health Department Were Critical in Controlling a 2019 Measles Outbreak in Southeast Michigan (SEM)

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S604-S605
Author(s):  
Trini Mathew ◽  
Paul Johnson ◽  
Diane Kamerer ◽  
Amber Jones ◽  
Jeffrey Ditkoff ◽  
...  
Keyword(s):  
Index Case ◽  
Beaumont Hospital ◽  
Health Department ◽  
Healthcare Personnel ◽  
Infectious Period ◽  
Local Health ◽  
Initial Report ◽  
Oakland County ◽  
County Health Department ◽  
Airborne Disease

Abstract Background Measles, declared eliminated in the US 2000, is a reemerging vaccine-preventable airborne disease. The 2019 case count (704 as of April 30, 2019) has surpassed the number of 2014 cases (667), the highest since 1994. Many healthcare personnel (HCP) have not seen a case of measles, and this lack of clinical experience may contribute to missed or delayed diagnoses leading to its spread. We describe the processes and measures implemented at Beaumont Hospital, Royal Oak (B-RO) Michigan in collaboration with the Oakland County Health Department (OCHD) to prevent secondary spread during an outbreak. Methods Soon after the initial report of the index case in Oakland County in March, the B-RO epidemiology team connected with OCHD. As both exposed and suspected cases were expected to seek care at B-RO, a one-page informational document was sent to B-RO providers. This document detailed isolation precautions and testing methods, post-exposure prophylaxis (PEP), and contact information. During subsequent days, as measles cases increased, frequent calls between B-RO and OCHD addressed numerous issues, including: media notifications, contact of exposed persons, vaccine and immunoglobulin supply for PEP, safe referral of cases to the EC, and the process of measles specimen submission for testing. As needed, these communications occurred after business hours and during weekends. Serologic testing to confirm measles immunity was ramped up. Results As of April 30, 41 cases have been confirmed in MI associated with the index case. OCHD facilitated the exposure control for 40 patients, of which 6 came to B-RO during their infectious period (Figure 1). To date, there have been no secondary cases developing in B-RO patients, HCPs or visitors, which may be related to successful engineering controls, appropriate protective equipment, mandatory measles immunity confirmation as condition of Beaumont employment since the late 1980s, institution of furlough procedures, PEP for hospitalized patients, and widespread communications with patients, visitors and HCPs (Figure 2). Conclusion During an outbreak, close healthcare facility and local health department collaboration is essential in rapidly limiting an airborne disease outbreak. Disclosures All authors: No reported disclosures.

Sign in / Sign up

Export Citation Format

Share Document